27.08.2013 • NewsBASFDede WillamsGreen Chemistry

BASF Expanding Waterborne Automotive Coatings in Brazil

BASF will spend €2.5 million to expand capacity for waterborne automotive coatings at its Demarchi coatings site in Brazil's Sao Paulo state by 2014. The upgrade, which the German group said is in response to customer demand, will encompass both waterborne primer and basecoats.

Antonio Carlos Lacerda, senior vice president of the Functional Solutions segment and Infrastructure for BASF South America, said demand is being driven by new automotive production facilities in Brazil as well as by the trend to replace solvent-borne technology with waterborne processes.

BASF, which helped pioneer waterborne coatings development in the early 1990s, said its technology is eco-efficient because water replaces most of the organic solvent, thus reducing emissions of volatile organic compounds (VOC). It also is claimed to reduce energy consumption and CO2 emissions by up to 20%.

 

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.